Costantino, Sarah
Mengozzi, Alessandro
Velagapudi, Srividya
Mohammed, Shafeeq Ahmed
Gorica, Era
Akhmedov, Alexander
Mongelli, Alessia
Pugliese, Nicola Riccardo
Masi, Stefano
Virdis, Agostino
Hülsmeier, Andreas
Matter, Christian Matthias
Hornemann, Thorsten
Melina, Giovanni
Ruschitzka, Frank
Luscher, Thomas Felix
Paneni, Francesco
Funding for this research was provided by:
Swiss Life Foundation
Holcim Foundation
Gebauer Stiftung
Swiss Heart Foundation (FF19045)
Italian Society of Arterial Hypertension
H.H. Sheikh Khalifa bin Hamad Al Thani Foundation Assistant Professorship
Swiss National Science Foundation (310030_197557)
Stiftung für wissenschaftliche Forschung
Olga Mayenfisch Foundation
Kurt und Senta-Hermann Stiftung
EMDO Stiftung
Schweizerische Diabetes-Stiftung
Article History
Received: 19 September 2023
Accepted: 7 November 2023
First Online: 13 November 2023
Declarations
:
: Animal experiments were carried out in accordance with our institutional guidelines and were approved by the Canton Zürich veterinary authorities. The study protocol for human samples’ collection and processing was approved by the Local Ethics Committee, and in accordance with institutional guidelines.
: Not applicable.
: T.F.L. has outside this work received research and educational grants to the institution Abbott, Amgen, AstraZeneca, Boehringer-Ingelheim, Daichi-Sankyo, Menarini Foundation, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi and Vifor and honoraria from Amgen, Dacadoo, Daichi-Sankyo, Menarini Foundation, Novartis, Novo Nordisk, Philips and Pfizer. F.R. has not received personal payments from pharmaceutical companies or device manufacturers in the last three years (remuneration for the time spent in activities, such as participation as steering committee member of clinical trials and member of the Pfizer Research Award selection committee in Switzerland, were made directly to the University of Zurich). The Department of Cardiology (University Hospital of Zurich/University of Zurich) reports research-, educational- and/or travel grants from Abbott, Amgen, Astra Zeneca, Bayer, Berlin Heart, B. Braun, Biosense Webster, Biosensors Europe AG, Biotronik, BMS, Boehringer Ingelheim, Boston Scientific, Bracco, Cardinal Health Switzerland, Corteria, Daiichi, Diatools AG, Edwards Lifesciences, Guidant Europe NV (BS), Hamilton Health Sciences, Kaneka Corporation, Kantar, Labormedizinisches Zentrum, Medtronic, MSD, Mundipharma Medical Company, Novartis, Novo Nordisk, Orion, Pfizer, Quintiles Switzerland Sarl, Sahajanand IN, Sanofi, Sarstedt AG, Servier, SIS Medical, SSS International Clinical Research, Terumo Deutschland, Trama Solutions, V-Wave, Vascular Medical, Vifor, Wissens Plus, ZOLL. The research and educational grants do not impact F.R.’s personal remuneration. F.P. has received personal fees from Novo Nordisk and is a scientific consultant for Vectura Pharma.